Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups
Authors:
- Giorgio BoganiGBGiorgio Bogani
- Giovanni ApoloneGAGiovanni Apolone
- Antonino DittoADAntonino Ditto
- Giovanni ScambiaGSGiovanni Scambia
- Pierluigi Benedetti PaniciPPPierluigi Benedetti Panici
- Roberto AngioliRARoberto Angioli
- Sandro PignataSPSandro Pignata
- Stefano GreggiSGStefano Greggi
- Paolo ScolloPSPaolo Scollo
- Mezzanzanica DeliaMezzanzanica Delia
- Massimo FranchiMFMassimo Franchi
- Fabio MartinelliFabio Martinelli
Open Access
- 1 January 2020
- journal article
- research article
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 31 (6) , e92
Abstract
Bogani G, et al. J Gynecol Oncol. 2019 Jun;31:e92. https://doi.org/10.3802/jgo.2020.31.e92Keywords
This publication has 20 references indexed in Scilit:
- The official French guidelines to protect patients with cancer against SARS-CoV-2 infectionThe Lancet Oncology, 2020
- COVID-19 Global Pandemic: Options for Management of Gynecologic CancersInternational Journal of Gynecological Cancer, 2020
- The Italian health system and the COVID-19 challengeThe Lancet Public Health, 2020
- Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemicNature Reviews Clinical Oncology, 2020
- Monitoring behavioural insights related to COVID-19The Lancet, 2020
- Minimally Invasive Surgery and the Novel Coronavirus Outbreak: Lessons Learned in China and ItalyAnnals of Surgery, 2020
- First Case of 2019 Novel Coronavirus in the United StatesNew England Journal of Medicine, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Community acquired respiratory and gastrointestinal viral infectionsCurrent Opinion in Infectious Diseases, 2012
- Non-response bias in a web-based health behaviour survey of New Zealand tertiary studentsPreventive Medicine, 2011